Establishing a Multiple Myeloma Drug Screening Platform to Predict Patient Response to Therapy

Establishing a Multiple Myeloma Drug Screening Platform to Predict Patient Response to Therapy

Establishing a Multiple Myeloma Drug Screening Platform to Predict Patient Response to Therapy


Dr. Indryas Woldie

University of Windsor

 

Dr. Woldie’s work will determine the efficacy of a promising new therapy for the treatment of multiple myeloma with the aim that this cutting edge treatment may bring new hope to patients in Windsor-Essex

Related Programs:
Nucleus Cores:

FUNDER:

Seeds4Hope

GRANT DURATION:

2019-2021

 

Loading...